Medicamen Biotech Limited has informed the Exchange regarding 'Declaration under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended March 31, 2025'.
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech has filed its yearly compliance declaration under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, as required by the promoter/promoter group. This is a routine annual filing confirming the promoter's compliance status regarding acquisitions or disposals during the financial year ended March 31, 2025. No specific figures regarding share movement, pledges, or holdings are disclosed in the headline itself. The filing is procedural in nature and falls under the standard disclosure regime for promoter-level ownership changes.
This is a routine annual compliance filing with no immediate material impact on the stock price or shareholder value. Investors should look for the detailed disclosure in the accompanying statement to check if any pledging, stake changes, or FII holding shifts occurred during the year.